Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
83 studies found for:    "Familial Mediterranean fever"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever
Intervention: Drug: Canakinumab
2 Completed
Has Results
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
Condition: Familial Mediterranean Fever
Interventions: Drug: Rilonacept;   Drug: Placebo
3 Withdrawn Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
Condition: Familial Mediterranean Fever
Intervention:
4 Enrolling by invitation Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
Condition: Familial Mediterranean Fever
Intervention: Other: Colchicine Cessation
5 Recruiting Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Condition: Familial Mediterranean Fever (FMF)
Intervention:
6 Completed Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever,
Intervention: Drug: Kineret
7 Completed Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)
Condition: Colchicine Resistant/Intolerant Familial Mediterranean Fever
Intervention: Drug: Canakinumab
8 Completed The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF
Condition: Familial Mediterranean Fever
Intervention: Drug: colchicine
9 Withdrawn The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.
Condition: Familial Mediterranean Fever (FMF )
Interventions: Dietary Supplement: probiotic;   Dietary Supplement: Placebo
10 Completed Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
Condition: Familial Mediterranean Fever
Intervention: Drug: colchicine sprinkle capsules
11 Unknown  Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
Condition: Familial Mediterranean Fever
Intervention:
12 Active, not recruiting Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
Condition: Hereditary Periodic Fevers
Interventions: Drug: canakinumab;   Drug: Placebo
13 Not yet recruiting An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Condition: Periodic Fevers Syndrome
Intervention: Biological: canakinumab
14 Not yet recruiting Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
Condition: Periodic Fever
Intervention: Drug: Canakinumab
15 Enrolling by invitation Heat Intolerance in the Group of FMF Patients
Conditions: Familial Mediterranean Fever;   Heat Intolerance;   Heat Tolerance Test
Intervention:
16 Unknown  Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever
Condition: Basal Proteinuria in Pregnancy
Intervention:
17 Not yet recruiting Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)
Conditions: Periodic Fever;   Aphthous Stomatitis;   Pharyngitis;   Cervical Adenitis
Interventions: Biological: Lactobacillus acidophilus and Bifidobacterium lactis;   Other: Placebo
18 Completed
Has Results
Interleukin-1 Trap to Treat Autoinflammatory Diseases
Conditions: Inflammation;   Familial Mediterranean Fever;   Still's Disease, Adult-Onset
Intervention: Drug: IL-1 Trap
19 Unknown  Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Conditions: Mevalonic Aciduria;   Mevalonate Kinase Deficiency;   Immune System Diseases;   Periodic Fever Syndromes, Hereditary;   Lipid Metabolism, Inborn Errors
Intervention:
20 Completed Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
Condition: DIRA
Intervention: Drug: Rilonacept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.